US20060241376A1 - Non-invasive left ventricular volume determination - Google Patents
Non-invasive left ventricular volume determination Download PDFInfo
- Publication number
- US20060241376A1 US20060241376A1 US10/554,021 US55402105A US2006241376A1 US 20060241376 A1 US20060241376 A1 US 20060241376A1 US 55402105 A US55402105 A US 55402105A US 2006241376 A1 US2006241376 A1 US 2006241376A1
- Authority
- US
- United States
- Prior art keywords
- endocardial
- volume
- contours
- cardiac cycle
- cardiac
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Images
Classifications
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/0002—Inspection of images, e.g. flaw detection
- G06T7/0012—Biomedical image inspection
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T7/00—Image analysis
- G06T7/60—Analysis of geometric attributes
- G06T7/62—Analysis of geometric attributes of area, perimeter, diameter or volume
-
- G—PHYSICS
- G06—COMPUTING; CALCULATING OR COUNTING
- G06T—IMAGE DATA PROCESSING OR GENERATION, IN GENERAL
- G06T2207/00—Indexing scheme for image analysis or image enhancement
- G06T2207/30—Subject of image; Context of image processing
- G06T2207/30004—Biomedical image processing
- G06T2207/30048—Heart; Cardiac
Definitions
- This invention pertains in general to the field of four dimensional image analyses and more particularly to the analysis of a cine sequence of captured cardiac images and even more particularly to left ventricular volume determination from a cine sequence of captured cardiac images.
- Magnetic Resonance Imaging is more and more getting accepted as the golden standard for this volume assessment because of its superior spatio temporal and ‘anatomical’ resolution.
- Magnetic (MRI) is an imaging technique used primarily in medical settings to produce high quality images of the inside of the human body.
- MRI is based on the principles of nuclear magnetic resonance (NMR) and has advanced to a volume imaging technique. Slices having a defined slice thickness are composed of several volume elements or voxels. The volume of a voxel is calculated as the inplane resolution within the slice, e.g.
- the magnetic resonance image is composed of several picture elements called pixels.
- the intensity of a pixel is proportional to the NMR signal intensity of the contents of the corresponding volume element or voxel of the object being imaged.
- a short-axis study of the heart consists of multiple slices covering a certain portion of the heart and multiple phases within the cardiac cycle.
- the study is captured by means of a device for imaging inside parts of a mammal body, such as e.g. Magnetic Resonance (MR), Computer Tomography (CT), Ultrasound (US) or Nuclear Medicine (NM) devices.
- MR Magnetic Resonance
- CT Computer Tomography
- US Ultrasound
- NM Nuclear Medicine
- a full cardiac contraction cycle i.e. one heartbeat from end-diastole (heart fully relaxed, ED) to end-systole (heart fully contracted, ES) and back to ED, is typically obtained at approximately 20 phases in the cardiac cycle.
- the approach that is generally taken to measure the LV volume from MR images consists of two steps. First the endocardial contours, i.e. the inner myocardium boundaries, are delineated in all MR images of a MR cardiac study, usually short-axis slices.
- the myocardium is the heart's muscular wall. It contracts to pump blood out of the heart, then relaxes as the heart refills with returning blood. Its outer surface is called the epicardium and its inner lining is called the endocardium.
- the LV volume is calculated on the basis of the area within the contour and knowledge about the slice distance and thus the voxel volume.
- Another method of determining LV volume is disclosed in U.S. Pat. No. -B1-6,438,403.
- a seed voxel is within the image area of the LV chamber is identified and the intensity values of neighbouring voxels are compared to a threshold to determine whether the voxel corresponds to blood or muscle tissue.
- For each neighbour voxel corresponding to blood its neighbour voxels are identified and compared to the threshold, whereby this process is repeated until a pre-established spatial boundary is encountered or the number of new neighbour voxels indicates that processing is migrating into an adjacent cardiac chamber.
- the number of identified blood voxels is used for calculating ventricular volume. A large number of voxels has to be compared to neighbouring voxels.
- One object of the invention is a reliable way of non-invasively determining LV volume during a cardiac cycle. Another object is to provide a method being less computational demanding than the prior art methods, so that results are faster available.
- the present invention overcomes the above-identified deficiencies in the art and solves at least the above identified problems by providing a method and a computer readable medium comprising a computer program according to the appended patent claims.
- the general solution according to the invention is to estimate LV volume using only endocardial contours in the 3D image that was acquired at end diastole (ED), i.e. the moment at which the heart is fully relaxed. These contours may be manually specified or (semi-)automatically derived. Based on these contours and on the pixel intensity in all other images, the LV volume is estimated.
- ED end diastole
- the image based LV volume determination method according to the invention is based on intensity variations within the cine series.
- the theory behind this is based on the following:
- the signal intensity of blood is approximately constant through out the cardiac cycle independently of the imaging method used for acquiring the images, such as e.g. MR, CT, US, NM.
- the intensity of blood significantly differs from that of the myocardium; for CT and MR blood is brighter than the myocardial tissue and the blood intensity is very strong, much stronger than that of myocardium or lung tissue, and of comparable intensity to any epicardial fat that may be present.
- CT and MR blood is brighter than the myocardial tissue and the blood intensity is very strong, much stronger than that of myocardium or lung tissue, and of comparable intensity to any epicardial fat that may be present.
- US and NM blood is usually dark and the myocardial tissue is brighter.
- there is a intensity contrast between myocardial tissue and blood independently from the imaging device/method used.
- a method and a computer-readable medium for determining total left ventricular (LV) volume during a cardiac cycle from a by means of a device for imaging inside parts of a mammal body captured cine series of cardiac images are disclosed.
- the device for imaging inside parts of a mammal body are a Magnetic Resonance (MR), Computer Tomography (CT) or Nuclear Medicine (NM) modality or a Ultrasound (US) Device.
- MR Magnetic Resonance
- CT Computer Tomography
- NM Nuclear Medicine
- US Ultrasound
- a method determines total left ventricular (LV) volume during a cardiac cycle from a cardiac cine series.
- the method comprises the steps of delineating endocardial and epicardial contours of a left ventricle in all slices of the cardiac cine series at end-diastole (ED) and subsequently applying these endocardial contours, which were delineated at ED, to all phases of the cardiac cycle, and calculating the total LV volume based on intensity values inside these endocardial contours delineated at ED.
- a computer-readable medium having embodied thereon a computer program for processing by a computer for calculating total left ventricular (LV) volume during a cardiac cycle from a cardiac cine series.
- the computer program comprises a first code segment for delineating endocardial and epicardial contours of a left ventricle in all slices of a cardiac cine series at end-diastole (ED), a second code segment for applying the endocardial contours delineated at ED to all phases of the cardiac cycle, and a third code segment for calculating the total LV volume based on intensity values inside the endocardial contours delineated at ED.
- ED end-diastole
- the present invention has the advantage over the prior art that it provides a reliable non-invasive fast evaluation of LV volume during cardiac cycles. Furthermore the determination of LV volume according to the invention is highly accurate and reproducible.
- FIG. 1 is a perspective view schematically illustrating the term “short axis”
- FIG. 2A is a cardiac MR image showing delineated endo- and epicardial walls of the LV myocardium in ED;
- FIG. 2B is a schematic illustration of FIG. 2A ;
- FIG. 3A is a cardiac MR image showing delineated endo- and epicardial walls of the LV myocardium in ES;
- FIG. 3B is a schematic illustration of FIG. 3A ;
- FIG. 4A is a cardiac MR sequence of 8 MR images during the cardiac cycle from ED to ES with delineations of the endocardial and epicardial wall of the LV myocardium derived at ED and copied to the subsequent phases;
- FIG. 4B is a schematic illustration of FIG. 4A ;
- FIG. 5 is a flow chart illustrating an embodiment of the method according to the invention.
- FIGS. 6 and 7 are graphs illustrating the variation of total LV volume during a cardiac cycle calculated according to the method of the invention for two patients compared to manual delineated calculation of the whole sequence;
- FIG. 8 is a set of graphs illustrating the variation of LV volume in different MR slices during a cardiac cycle calculated according to the method of the invention for six patients compared to manual delineated calculation of the whole sequence;
- FIG. 9 is a schematic diagram illustrating an embodiment of the computer-readable medium according to the invention.
- a method 10 is shown.
- the LV volume is calculated over a cardiac cycle by evaluating a short-axis MRI cine series of the heart consisting of multiple slices covering the whole heart and multiple phases within the cardiac cycle.
- the MRI cine series of the cardiac cycle is not limited to MRI cine series and the MRI cine series of the embodiment as described herein is not limiting.
- the method according to the invention may determine LV volume from any cardiac cine series, independently from the method or device by means of which the cardiac cine series is captured.
- the definition of a short-axis slice is illustrated in FIG. 1 , wherein a long axis 2 and a short-axis slice 3 are shown.
- the schematic illustration of cardiac components 1 shows the left ventricle 6 , the right ventricle 7 , the myocardium 4 , the epicardium 8 and the endocardium 5 .
- the first image in a MRI cine series corresponds to the ED phase in the cardiac cycle. This assumption is not true for all of the image sets that are used; the first image is however at most two images away from the ED phase.
- the ED phase being defmed here as the phase at which the in-slice volume contained by a manually created endocardial contour is greatest.
- a simple re-ordering of the images can be done so that it becomes the first image.
- the blood volume at any subsequent phase in the cardiac cycle will be less than the blood volume at ED.
- Manual observation of the heart shows a tendency for the epicardial contour, i.e. the outer boundaries of the myocardium, to stay relatively fixed throughout the cardiac cycle, and the endocardial surface to move inwards, approximately towards the centroid of the left ventricular blood pool, as it approaches ES. This can be seen in the exemplary image sequence shown in FIG. 4 .
- Endocardial delineation performed at ED will thus contain the LV blood pool for all slices, when the ED endocardial delineation is copied onto all subsequent phases. It is also, due to the relatively stationary nature of the epicardial surface, unlikely to contain the epicardial surface, or any organs beyond that Such a delineation, copied to all subsequent phases will hence contain signals that originate solely from the LV myocardium and LV blood pool.
- Any motion of the heart may automatically be compensated with (rigid) registration techniques such as motion compensation used for 1 st -pass myocardial perfusion MR image series, as e.g. described in M. Breeuwer, M. Quist, L. Spreeuwers, I. Paetsch, N. Al-Saadi and E. Nagel, “Towards automatic quantitative analysis of cardiac MR perfusion images”, Proceedings CARS 2001, June 2001, Berlin, Germany.
- FIG. 3A is an exemplary MR image 300 ( FIG. 3A ) and a corresponding schematic illustration 301 is shown in FIG. 3B .
- the endocardium delineation at ES is delineated with the line 31 indicated in FIGS. 3A and 3B .
- the LV blood pool at ES is shown at 32 .
- the epicardium delineation 30 at ES is approximately the same as the epicardium delineation 20 at ED.
- FIGS. 4A and 4B illustrate a cine sequence from ED 41 to ES 42 over time t.
- FIG. 4A is an exemplary MR cine sequence 400 and a corresponding schematic illustration 401 is shown in FIG. 4B .
- Line 45 indicates the endocardium boundary at subsequent phases after ED and contains the blood pool 46 .
- the dotted line 21 from ED to ES indicates the endocardium delineation made at ED.
- n is the total number of slices comprising the LV total volume
- V ED,i is the calculated volume of slice number i of the LV at end-diastole of the LV
- I T,i is the detected intensity of slice i within the endocardial delimitation
- IT is the total intensity at ED. This is performed in step 53 of the illustrated method.
- V LV is a function of time t and varies during the cardiac cycle as described above (maximum at ED, minimum at ES). Two examples of calculated V LV (t) are shown as continuous lines in FIGS. 6 and 7 . Therefore it is checked in step 54 of the method, if the LV volume has been calculated for all phases of the examined cardiac cycle from the MR cine 20 . series. Until all LV volumes for all phases are calculated, the method branches back to step 53 , by increasing to the next phase slices in step 55 and calculating the intensities within the copied ED endocardial delineation as described above. In this way the LV volume for all slices is summed up to a total LV volume for each phase, fmally resulting in the total LV volume over the whole MR cine series as shown in the graphs in FIGS. 6 and 7 .
- Short axis electrocardiogram triggered steady state free precession SENSE images were obtained in ten patients undergoing cardiac MRI for the investigation of coronary artery disease.
- Three slices corresponding to approximately basal, mid and apical positions were selected from 8-9 contiguous slices, imaged with slice thickness 8-10 mm; field of view 350 ⁇ 344-390 ⁇ 390 mm; image size 256 ⁇ 256; 20-25 phases in the cardiac cycle; flip angle 50-55°; TE 1.56-1.68 ms; TR 3.11-3.37 ms.
- the images were acquired on a Philips Gyrostan Intera 1.5 T with master gradients, using a five-element cardiac synergy coil, and vector electrocardiogram.
- the graphs in FIGS. 6 to 8 show similar shape and features to the volumes produced by the manual delineations.
- FIG. 9 shows a schematic diagram over another embodiment 9 of the invention.
- a computer-readable medium 90 has embodied thereon a computer program for processing by a computer 91 for calculating total left ventricular (LV) volume during a cardiac cycle from a MRI cine series is provided.
- the computer program comprises a first code segment 92 for delineating endocardial and epicardial contours of a left ventricle in all slices of a MR cine series at end-diastole (ED), a second code 93 segment for applying the endocardial contours delineated at ED to all phases of the cardiac cycle, and a third code segment 94 for calculating the total LV volume based on intensity values inside the endocardial contours delineated at ED.
- the computer is generally a general purpose computer.
- SSFP MR images are especially well suited for the LV volume determination according to the invention because the signal intensity of blood in SSFP MR images is approximately constant through out the cardiac cycle.
- the method can also be used as a first step in the temporal registration of LV functional images acquired at different stress levels.
- LV function is usually assessed at a number of (pharmacologically induced) stress levels (4-5 levels).
- the temporal behaviour of the heart as a function of increasing stress is highly non-linear, which means that the resulting phases cannot simply be matched by linear scaling of the temporal axis.
- the temporal scaling may be performed using the measured LV volume curves as one of the inputs. In these curves, the contraction and relaxation intervals may for example be determined and these intervals may be matched between the stress levels.
- CMR functional cardiac MR
- phase information there are several manners in which one could derive such phase information, the two principle manners from which one might determine the phase are, from a simultaneously recorded ECG signal, or from the actual image data.
- the determination of phase in the cardiac cycle is performed via analysis of the MRI cine image series.
- the most obvious and most frequently used image derived method of determining phase is via manual observation of the cine series.
- an analysis of the volume contained by delineations of the left ventricular endocardial surface can be performed. This has been used to identify end-diastole and end-systole in the commercially available MASS package (Version 4.2, Medis, Leiden, the Netherlands).
- MASS package Version 4.2, Medis, Leiden, the Netherlands.
- the ED and ES phases are identified, where a representation of the entire cardiac cycle is required, linear interpolation between these points has been performed.
- a set of endocardial delineations, whether manually, or automatically produced contain sufficient data to perform a detailed analysis of the phase in the cardiac cycle.
- automatic delineation techniques encounter difficulties when delineating as described above.
- an pre-processing step is to invert the images before applying the LV volume measurement method according to the invention.
- the method according to the invention is generally implemented on a general purpose computer. However, the method may also be implemented in dedicated solutions, such as code segments for execution by e.g. a DSP chip, a specifically designed integrated circuit such as an ASIC, etc.
Abstract
Description
- This invention pertains in general to the field of four dimensional image analyses and more particularly to the analysis of a cine sequence of captured cardiac images and even more particularly to left ventricular volume determination from a cine sequence of captured cardiac images.
- The assessment of the blood volume of the left ventricle (LV) of the heart as a function of time is of importance for the evaluation of the pump function of the heart. Magnetic Resonance Imaging (MRI) is more and more getting accepted as the golden standard for this volume assessment because of its superior spatio temporal and ‘anatomical’ resolution. Magnetic (MRI) is an imaging technique used primarily in medical settings to produce high quality images of the inside of the human body. MRI is based on the principles of nuclear magnetic resonance (NMR) and has advanced to a volume imaging technique. Slices having a defined slice thickness are composed of several volume elements or voxels. The volume of a voxel is calculated as the inplane resolution within the slice, e.g. 3 mm2, multiplied with the through-plane resolution, i.e. the slice distance, e.g. 3 mm, which results in a voxel volume of 3mm3 for the given example. The magnetic resonance image is composed of several picture elements called pixels. The intensity of a pixel is proportional to the NMR signal intensity of the contents of the corresponding volume element or voxel of the object being imaged.
- A short-axis study of the heart consists of multiple slices covering a certain portion of the heart and multiple phases within the cardiac cycle. The study is captured by means of a device for imaging inside parts of a mammal body, such as e.g. Magnetic Resonance (MR), Computer Tomography (CT), Ultrasound (US) or Nuclear Medicine (NM) devices. The sequence of images is available for further analysis.
- For the assessment of LV volume the left and right ventricle are covered from apex (bottom) to base (valvular plane) in such a study. Thus four-dimensional images of the heart are available. Multiple slices (approximately 10 to 15) compose a three dimensional image of the heart. The fourth dimension is time. A full cardiac contraction cycle, i.e. one heartbeat from end-diastole (heart fully relaxed, ED) to end-systole (heart fully contracted, ES) and back to ED, is typically obtained at approximately 20 phases in the cardiac cycle.
- The approach that is generally taken to measure the LV volume from MR images consists of two steps. First the endocardial contours, i.e. the inner myocardium boundaries, are delineated in all MR images of a MR cardiac study, usually short-axis slices. The myocardium is the heart's muscular wall. It contracts to pump blood out of the heart, then relaxes as the heart refills with returning blood. Its outer surface is called the epicardium and its inner lining is called the endocardium. Thereafter the LV volume is calculated on the basis of the area within the contour and knowledge about the slice distance and thus the voxel volume.
- Several methods for automatic delineation of the LV endocardial contours have been proposed. However, so far none of these can perform a true automatic delineation, since the clinical user has to perform a significant number of manual contour corrections. In the presence of papiliary muscles and trabeculae, at apical positions in the myocardium or when delineating the ES phase, spurious results are produced by the methods according to the prior art. The vast amount of clinician time is required to perform a set of delineations on a typical MRI cine series, i.e. approximately 400 delineations per series or several hours of manual work. For
instance 20phases times 10slices times 2 contours=400contours times 10 sec per contour=1 hour and 11 minutes; in reality however this may have to be done for 4-5 stress levels, so the total time can be up to 5 hours. This time constraint is prohibitive to the routine incorporation of manual delineation in LV volume determination. - Another method of determining LV volume is disclosed in U.S. Pat. No. -B1-6,438,403. A seed voxel is within the image area of the LV chamber is identified and the intensity values of neighbouring voxels are compared to a threshold to determine whether the voxel corresponds to blood or muscle tissue. For each neighbour voxel corresponding to blood, its neighbour voxels are identified and compared to the threshold, whereby this process is repeated until a pre-established spatial boundary is encountered or the number of new neighbour voxels indicates that processing is migrating into an adjacent cardiac chamber. The number of identified blood voxels is used for calculating ventricular volume. A large number of voxels has to be compared to neighbouring voxels. This method is complicated and demanding with regard to computational power. Depending on the power of the computer equipment used to perform the calculations, it takes either a long time to get a calculated result or if fast equipment is used, this means that it is expensive in terms of money to carry out the calculation. Another drawback of this method is the fact that a seed voxel has to be identified either manually or automatically, which in both cases is prone to errors. Furthermore the method of seeded region growing has the general disadvantage that it can only detect the volume in which the seed is positioned. If, for example, due to the specific geometry of the papillary muscles the LV volume consists of two non-connected subvolumes one of the two may be missed and the LV volume calculated according to the method of U.S. Pat. No. -B1-6,438,403 is not correct.
- One object of the invention is a reliable way of non-invasively determining LV volume during a cardiac cycle. Another object is to provide a method being less computational demanding than the prior art methods, so that results are faster available.
- The present invention overcomes the above-identified deficiencies in the art and solves at least the above identified problems by providing a method and a computer readable medium comprising a computer program according to the appended patent claims.
- The general solution according to the invention is to estimate LV volume using only endocardial contours in the 3D image that was acquired at end diastole (ED), i.e. the moment at which the heart is fully relaxed. These contours may be manually specified or (semi-)automatically derived. Based on these contours and on the pixel intensity in all other images, the LV volume is estimated.
- More particularly, the image based LV volume determination method according to the invention is based on intensity variations within the cine series. The theory behind this is based on the following:
- The signal intensity of blood is approximately constant through out the cardiac cycle independently of the imaging method used for acquiring the images, such as e.g. MR, CT, US, NM.
- The intensity of blood significantly differs from that of the myocardium; for CT and MR blood is brighter than the myocardial tissue and the blood intensity is very strong, much stronger than that of myocardium or lung tissue, and of comparable intensity to any epicardial fat that may be present. In US and NM blood is usually dark and the myocardial tissue is brighter. Thus there is a intensity contrast between myocardial tissue and blood, independently from the imaging device/method used.
- Changes in the histogram across the cardiac cycle are dominated by the strong signal coming from the blood in the ventricles as they change size.
- This change is proportional to the change in size of the ventricles, this measure provides hence a way for determining the ventricle volume and other derivable cardiac functionality parameters as well as the phase in the cardiac cycle.
- According to aspects of the invention, a method and a computer-readable medium for determining total left ventricular (LV) volume during a cardiac cycle from a by means of a device for imaging inside parts of a mammal body captured cine series of cardiac images are disclosed. Preferably the device for imaging inside parts of a mammal body are a Magnetic Resonance (MR), Computer Tomography (CT) or Nuclear Medicine (NM) modality or a Ultrasound (US) Device.
- According to one aspect of the invention, a method is provided, wherein the method determines total left ventricular (LV) volume during a cardiac cycle from a cardiac cine series. The method comprises the steps of delineating endocardial and epicardial contours of a left ventricle in all slices of the cardiac cine series at end-diastole (ED) and subsequently applying these endocardial contours, which were delineated at ED, to all phases of the cardiac cycle, and calculating the total LV volume based on intensity values inside these endocardial contours delineated at ED.
- According to another aspect of the invention, a computer-readable medium having embodied thereon a computer program for processing by a computer for calculating total left ventricular (LV) volume during a cardiac cycle from a cardiac cine series is provided. The computer program comprises a first code segment for delineating endocardial and epicardial contours of a left ventricle in all slices of a cardiac cine series at end-diastole (ED), a second code segment for applying the endocardial contours delineated at ED to all phases of the cardiac cycle, and a third code segment for calculating the total LV volume based on intensity values inside the endocardial contours delineated at ED.
- The present invention has the advantage over the prior art that it provides a reliable non-invasive fast evaluation of LV volume during cardiac cycles. Furthermore the determination of LV volume according to the invention is highly accurate and reproducible.
- Further objects, features and advantages of the invention will become apparent from the following description of embodiments of the present invention, reference being made to the accompanying drawings, in which
-
FIG. 1 is a perspective view schematically illustrating the term “short axis”; -
FIG. 2A is a cardiac MR image showing delineated endo- and epicardial walls of the LV myocardium in ED; -
FIG. 2B is a schematic illustration ofFIG. 2A ; -
FIG. 3A is a cardiac MR image showing delineated endo- and epicardial walls of the LV myocardium in ES; -
FIG. 3B is a schematic illustration ofFIG. 3A ; -
FIG. 4A is a cardiac MR sequence of 8 MR images during the cardiac cycle from ED to ES with delineations of the endocardial and epicardial wall of the LV myocardium derived at ED and copied to the subsequent phases; -
FIG. 4B is a schematic illustration ofFIG. 4A ; -
FIG. 5 is a flow chart illustrating an embodiment of the method according to the invention; -
FIGS. 6 and 7 are graphs illustrating the variation of total LV volume during a cardiac cycle calculated according to the method of the invention for two patients compared to manual delineated calculation of the whole sequence; -
FIG. 8 is a set of graphs illustrating the variation of LV volume in different MR slices during a cardiac cycle calculated according to the method of the invention for six patients compared to manual delineated calculation of the whole sequence; and -
FIG. 9 is a schematic diagram illustrating an embodiment of the computer-readable medium according to the invention. - In an embodiment of the invention according to
FIG. 5 , amethod 10 is shown. According to themethod 10, the LV volume is calculated over a cardiac cycle by evaluating a short-axis MRI cine series of the heart consisting of multiple slices covering the whole heart and multiple phases within the cardiac cycle. The MRI cine series of the cardiac cycle is not limited to MRI cine series and the MRI cine series of the embodiment as described herein is not limiting. Moreover the method according to the invention may determine LV volume from any cardiac cine series, independently from the method or device by means of which the cardiac cine series is captured. The definition of a short-axis slice is illustrated inFIG. 1 , wherein along axis 2 and a short-axis slice 3 are shown. Furthermore the schematic illustration ofcardiac components 1 shows theleft ventricle 6, theright ventricle 7, themyocardium 4, theepicardium 8 and theendocardium 5. - It is assumed in the method that the first image in a MRI cine series corresponds to the ED phase in the cardiac cycle. This assumption is not true for all of the image sets that are used; the first image is however at most two images away from the ED phase. The ED phase being defmed here as the phase at which the in-slice volume contained by a manually created endocardial contour is greatest. In case the ED image is at another position of the cine sequence, a simple re-ordering of the images can be done so that it becomes the first image.
- Following this assumption, the blood volume at any subsequent phase in the cardiac cycle will be less than the blood volume at ED. Manual observation of the heart shows a tendency for the epicardial contour, i.e. the outer boundaries of the myocardium, to stay relatively fixed throughout the cardiac cycle, and the endocardial surface to move inwards, approximately towards the centroid of the left ventricular blood pool, as it approaches ES. This can be seen in the exemplary image sequence shown in
FIG. 4 . - Endocardial delineation performed at ED will thus contain the LV blood pool for all slices, when the ED endocardial delineation is copied onto all subsequent phases. It is also, due to the relatively stationary nature of the epicardial surface, unlikely to contain the epicardial surface, or any organs beyond that Such a delineation, copied to all subsequent phases will hence contain signals that originate solely from the LV myocardium and LV blood pool. Any motion of the heart may automatically be compensated with (rigid) registration techniques such as motion compensation used for 1st-pass myocardial perfusion MR image series, as e.g. described in M. Breeuwer, M. Quist, L. Spreeuwers, I. Paetsch, N. Al-Saadi and E. Nagel, “Towards automatic quantitative analysis of cardiac MR perfusion images”, Proceedings CARS 2001, June 2001, Berlin, Germany.
- By means of
endocardial delineation 21 andepicardial delineation 20 for the first image in the cine series (approximately ED) the mean voxel intensity of myocardium 23 (betweendelineations 20,21) is calculated. This is shown inFIGS. 2A and 2B in an exemplary MR image 200 (FIG. 2A ) and a corresponding schematic illustration 201 (FIG. 2B ) with theLV blood volume 22 inside theendocardial delineation 21. When theendocardial delineation 21 is copied and pasted to subsequent phases (as shown inFIGS. 4a and 4B ) and the contained voxels are integrated, the integral is principally due to the intensities of the blood and the myocardium contained, that is:
I T =I B =+I MYO (1) - Where IT is the total signal intensity, IB the signal intensity due to the blood and IMYO the signal intensity due to any myocardium that is contained by the contour. As can be seen in
FIGS. 3A, 3B andFIGS. 4A, 4B the endocardium moves towards the centroid of the LV blood volume.FIG. 3A is an exemplary MR image 300 (FIG. 3A ) and a correspondingschematic illustration 301 is shown inFIG. 3B . The endocardium delineation at ES is delineated with theline 31 indicated inFIGS. 3A and 3B . The LV blood pool at ES is shown at 32. Theepicardium delineation 30 at ES is approximately the same as theepicardium delineation 20 at ED. Thus the contribution of the myocardium to the total intensity will increase from ED (image 41 inFIG. 4A ) to ES (image 42 inFIG. 4A ) and decrease from ES back to ED. Other contributions may arise from the lung, the right ventricular blood pool and epicardial fat. These will only occur if the heart moves sufficiently for these to be covered by the endocardial contour at subsequent phases. -
FIGS. 4A and 4B illustrate a cine sequence fromED 41 toES 42 over time t.FIG. 4A is an exemplaryMR cine sequence 400 and a correspondingschematic illustration 401 is shown inFIG. 4B .Line 45 indicates the endocardium boundary at subsequent phases after ED and contains theblood pool 46. The dottedline 21 from ED to ES indicates the endocardium delineation made at ED. - The total area contained by the contour (AT), is equal to the sum of the areas due to the blood (AB) and the myocardium (AMYO), such that:
A T =A B +A Myo (2) - These areas are calculated in
step 51. - Calculating the mean intensity per voxel, for both myocardium (SMYO) and blood (SB), is performed in
step 52 of the method, wherein both are calculated from the initial endocardial and epicardial delineations, and assuming that the signal intensity is proportional to the area contained, it is:
I B =A B ×S B (3)
and
I MYO =A MYO ×S MYO (4) - Solving
equations - The total LV volume VLV filled with blood in a certain phase of a CMR cardiac cycle is thus calculated as:
- wherein n is the total number of slices comprising the LV total volume, VED,i is the calculated volume of slice number i of the LV at end-diastole of the LV, IT,i is the detected intensity of slice i within the endocardial delimitation and IT, ED is the total intensity at ED. This is performed in
step 53 of the illustrated method. - VLV is a function of time t and varies during the cardiac cycle as described above (maximum at ED, minimum at ES). Two examples of calculated VLV (t) are shown as continuous lines in
FIGS. 6 and 7 . Therefore it is checked instep 54 of the method, if the LV volume has been calculated for all phases of the examined cardiac cycle from theMR cine 20. series. Until all LV volumes for all phases are calculated, the method branches back to step 53, by increasing to the next phase slices instep 55 and calculating the intensities within the copied ED endocardial delineation as described above. In this way the LV volume for all slices is summed up to a total LV volume for each phase, fmally resulting in the total LV volume over the whole MR cine series as shown in the graphs inFIGS. 6 and 7 . - Clinical studies were performed to validate the method. Short axis electrocardiogram triggered steady state free precession SENSE images were obtained in ten patients undergoing cardiac MRI for the investigation of coronary artery disease. Three slices corresponding to approximately basal, mid and apical positions were selected from 8-9 contiguous slices, imaged with slice thickness 8-10 mm; field of view 350×344-390×390 mm; image size 256×256; 20-25 phases in the cardiac cycle; flip angle 50-55°; TE 1.56-1.68 ms; TR 3.11-3.37 ms. The images were acquired on a Philips Gyrostan Intera 1.5 T with master gradients, using a five-element cardiac synergy coil, and vector electrocardiogram.
- For each selected slice, of each image set, both endocardial and epicardial delineations were manually performed on the first image. From these delineations, AT, SMYO and SB were calculated. For each subsequent image, IT was calculated by summing the intensity values of all of the voxels contained by the endocardial delineation. IB was then calculated according to
equation 5. - In order to verify the results, manual delineation was performed for every image and the number of voxels contained by that contour calculated. The number of voxels was multiplied by the volume of a single voxel to get a total endocardial volume for each image. The values of IB were normalised to the endocardial volume in order for them to be plotted on the same axes, by calculating the factor that forces the integral value for the first image to coincide with the volume contained by the manual delineation for that image. This factor was then applied to the intensity sums of all of the images of that slice. Graphs of the values produced can be seen in
FIG. 8 . These traces, follow their manually derived counterparts very well. The smooth nature of the intensity derived traces suggest a more plausible description of cardiac function than the ragged manually derived traces, which is due to the inherent error present in manual delineations. - The graphs in FIGS. 6 to 8 show similar shape and features to the volumes produced by the manual delineations.
- Further improvements to this method, or at least to the results, may incorporate a delineation of papiliary muscles and allow for their subsequent affect on volume measurements. It is anticipated that such a modification would serve to further improve the similarity of the graphs obtained.
-
FIG. 9 shows a schematic diagram over anotherembodiment 9 of the invention. A computer-readable medium 90 has embodied thereon a computer program for processing by acomputer 91 for calculating total left ventricular (LV) volume during a cardiac cycle from a MRI cine series is provided. The computer program comprises afirst code segment 92 for delineating endocardial and epicardial contours of a left ventricle in all slices of a MR cine series at end-diastole (ED), asecond code 93 segment for applying the endocardial contours delineated at ED to all phases of the cardiac cycle, and athird code segment 94 for calculating the total LV volume based on intensity values inside the endocardial contours delineated at ED. The computer is generally a general purpose computer. - When using MR images, Steady State Free Precession (SSFP) MR images are especially well suited for the LV volume determination according to the invention because the signal intensity of blood in SSFP MR images is approximately constant through out the cardiac cycle.
- Apart from the assessment of the LV volume, the method can also be used as a first step in the temporal registration of LV functional images acquired at different stress levels. LV function is usually assessed at a number of (pharmacologically induced) stress levels (4-5 levels). The temporal behaviour of the heart as a function of increasing stress is highly non-linear, which means that the resulting phases cannot simply be matched by linear scaling of the temporal axis. The temporal scaling may be performed using the measured LV volume curves as one of the inputs. In these curves, the contraction and relaxation intervals may for example be determined and these intervals may be matched between the stress levels.
- By means of the above described processing of functional cardiac MR (CMR) images, it is possible to determine at what point in the cardiac cycle a certain image was taken. These include: the determination of equivalent images in rest/stress data sets, the identification of ES for the optimisation of registration strategies or the assessment of tachycardia patients.
- There are several manners in which one could derive such phase information, the two principle manners from which one might determine the phase are, from a simultaneously recorded ECG signal, or from the actual image data. An alternative, although extremely invasive method, would be via an analysis of the measurements taken by an intra-ventricular pressure catheter. According to an embodiment of the invention, the determination of phase in the cardiac cycle is performed via analysis of the MRI cine image series.
- The most obvious and most frequently used image derived method of determining phase, is via manual observation of the cine series. Alternatively, an analysis of the volume contained by delineations of the left ventricular endocardial surface can be performed. This has been used to identify end-diastole and end-systole in the commercially available MASS package (Version 4.2, Medis, Leiden, the Netherlands). However, although the ED and ES phases are identified, where a representation of the entire cardiac cycle is required, linear interpolation between these points has been performed.
- A set of endocardial delineations, whether manually, or automatically produced contain sufficient data to perform a detailed analysis of the phase in the cardiac cycle. Currently, automatic delineation techniques encounter difficulties when delineating as described above.
- For those imaging modalities that show the myocardium brighter than the left ventricular blood pool an pre-processing step is to invert the images before applying the LV volume measurement method according to the invention.
- The method according to the invention is generally implemented on a general purpose computer. However, the method may also be implemented in dedicated solutions, such as code segments for execution by e.g. a DSP chip, a specifically designed integrated circuit such as an ASIC, etc.
- The present invention has been described above with reference to specific embodiments. However, other embodiments than the preferred above are equally possible within the scope of the appended claims, e.g. different ways of delineating the endocardial and epicardial contours than those described above, different ways of capturing the cine series, different ways of calculating intensities in the cine images, different slice thickness of the cine images, different number of phases/images representing the cardiac cycle, performing the above method by hardware or software, other image capturing devices or methods for acquiring the cardiac cine series, etc.
- Furthermore, the term “comprises/comprising” when used in this specification does not exclude other elements or steps, the terms “a” and “an” do not exclude a plurality and a single processor or other units may fulfil the functions of several of the units or circuits recited in the claims.
Claims (12)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP03101141 | 2003-04-24 | ||
EP03101141.4 | 2003-04-24 | ||
PCT/IB2004/050503 WO2004097720A1 (en) | 2003-04-24 | 2004-04-23 | Non-invasive left ventricular volume determination |
Publications (2)
Publication Number | Publication Date |
---|---|
US20060241376A1 true US20060241376A1 (en) | 2006-10-26 |
US7603154B2 US7603154B2 (en) | 2009-10-13 |
Family
ID=33395933
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
US10/554,021 Active 2024-07-17 US7603154B2 (en) | 2003-04-24 | 2004-04-23 | Non-invasive left ventricular volume determination |
Country Status (7)
Country | Link |
---|---|
US (1) | US7603154B2 (en) |
EP (1) | EP1620827B1 (en) |
JP (1) | JP2006524092A (en) |
CN (1) | CN100377165C (en) |
AT (1) | ATE470199T1 (en) |
DE (1) | DE602004027479D1 (en) |
WO (1) | WO2004097720A1 (en) |
Cited By (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20070253609A1 (en) * | 2006-04-28 | 2007-11-01 | Aben Jean-Paul M M | Method, Apparatus and Computer Program Product for Automatic Segmenting of Cardiac Chambers |
US20090149734A1 (en) * | 2007-12-07 | 2009-06-11 | Kabushiki Kaisha Toshiba | Diagnostic imaging apparatus, magnetic resonance imaging apparatus, and x-ray ct apparatus |
US20100303328A1 (en) * | 2008-01-31 | 2010-12-02 | Koninklijke Philips Electronics N.V. | Automatic 3-d segmentation of the short-axis late-enhancement cardiac mri |
WO2011107528A1 (en) | 2010-03-04 | 2011-09-09 | Europejskie Centrum Zdrowia Otwock Sp. Z O.O. | A device and a method for imaging the left ventricle of a heart |
US20120146632A1 (en) * | 2009-07-20 | 2012-06-14 | Koninklijke Philips Electronics N.V. | Apparatus and method for influencing and/or detecting magnetic particles |
US20140005526A1 (en) * | 2012-07-02 | 2014-01-02 | Assaf Govari | Catheter with synthetic aperture mri sensor |
US20150023577A1 (en) * | 2012-03-05 | 2015-01-22 | Hong'en (Hangzhou, China) Medical Technology Inc. | Device and method for determining physiological parameters based on 3d medical images |
WO2018140596A3 (en) * | 2017-01-27 | 2018-09-07 | Arterys Inc. | Automated segmentation utilizing fully convolutional networks |
US10398344B2 (en) | 2014-01-17 | 2019-09-03 | Arterys Inc. | Apparatus, methods and articles for four dimensional (4D) flow magnetic resonance imaging |
US10495713B2 (en) | 2011-07-07 | 2019-12-03 | The Board Of Trustees Of The Leland Stanford Junior University | Comprehensive cardiovascular analysis with volumetric phase-contrast MRI |
US10871536B2 (en) | 2015-11-29 | 2020-12-22 | Arterys Inc. | Automated cardiac volume segmentation |
US11515032B2 (en) | 2014-01-17 | 2022-11-29 | Arterys Inc. | Medical imaging and efficient sharing of medical imaging information |
US11551353B2 (en) | 2017-11-22 | 2023-01-10 | Arterys Inc. | Content based image retrieval for lesion analysis |
Families Citing this family (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2006524092A (en) | 2003-04-24 | 2006-10-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Non-invasive left ventricular volume determination |
WO2005076186A1 (en) | 2004-02-09 | 2005-08-18 | Institut De Cardiologie De Montreal | Computation of a geometric parameter of a cardiac chamber from a cardiac tomography data set |
JP4679141B2 (en) * | 2004-12-27 | 2011-04-27 | 株式会社東芝 | Ultrasonic diagnostic apparatus and method for displaying ultrasonic diagnostic image |
DE102006026695A1 (en) | 2006-06-08 | 2007-12-13 | Tomtec Imaging Systems Gmbh | Method, apparatus and computer program product for evaluating dynamic images of a cavity |
JP5751738B2 (en) * | 2007-12-07 | 2015-07-22 | 株式会社東芝 | Magnetic resonance imaging system |
US8218839B2 (en) * | 2008-05-23 | 2012-07-10 | Siemens Aktiengesellschaft | Automatic localization of the left ventricle in cardiac cine magnetic resonance imaging |
US8331638B2 (en) * | 2008-10-10 | 2012-12-11 | Siemens Corporation | Creation of motion compensated MRI M-mode images of the myocardial wall |
US10078893B2 (en) | 2010-12-29 | 2018-09-18 | Dia Imaging Analysis Ltd | Automatic left ventricular function evaluation |
EP2765916B1 (en) | 2011-10-12 | 2019-02-13 | The Johns Hopkins University | System for evaluating regional cardiac function and dyssynchrony from a dynamic imaging modality using endocardial motion |
US9734430B2 (en) | 2012-01-02 | 2017-08-15 | Mackay Memorial Hospital | Evaluation system or determination of cardiovascular function parameters |
JP6238672B2 (en) * | 2012-10-04 | 2017-11-29 | 東芝メディカルシステムズ株式会社 | Ultrasonic diagnostic equipment |
CN102961161A (en) * | 2012-11-27 | 2013-03-13 | 华南理工大学 | Method for automatically obtaining heart function parameters of four-dimensional heart |
KR101616029B1 (en) | 2014-07-25 | 2016-04-27 | 삼성전자주식회사 | Magnetic resonance imaging processing method and apparatus thereof |
KR101652046B1 (en) * | 2014-11-03 | 2016-08-29 | 삼성전자주식회사 | Medical imaging apparatus and processing method thereof |
US10674986B2 (en) | 2016-05-13 | 2020-06-09 | General Electric Company | Methods for personalizing blood flow models |
CN108882917A (en) * | 2016-05-30 | 2018-11-23 | 深圳迈瑞生物医疗电子股份有限公司 | A kind of heart volume discriminance analysis system and method |
PT3537977T (en) * | 2016-11-11 | 2023-08-23 | Medtrace Pharma As | Method and system for modelling a human heart and atria |
US10388015B2 (en) | 2017-09-06 | 2019-08-20 | International Business Machines Corporation | Automated septal defect detection in cardiac computed tomography images |
CN108703770B (en) * | 2018-04-08 | 2021-10-01 | 智谷医疗科技(广州)有限公司 | Ventricular volume monitoring device and method |
CN112656445B (en) * | 2020-12-18 | 2023-04-07 | 青岛海信医疗设备股份有限公司 | Ultrasonic device, ultrasonic image processing method and storage medium |
Citations (68)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5107838A (en) * | 1990-02-08 | 1992-04-28 | Kabushiki Kaisha Toshiba | Method of left ventricular volume evaluation using nuclear magnetic resonance imaging |
US5185809A (en) * | 1987-08-14 | 1993-02-09 | The General Hospital Corporation | Morphometric analysis of anatomical tomographic data |
US5195521A (en) * | 1990-11-09 | 1993-03-23 | Hewlett-Packard Company | Tissue measurements |
US5433199A (en) * | 1994-02-24 | 1995-07-18 | General Electric Company | Cardiac functional analysis method using gradient image segmentation |
US5435310A (en) * | 1993-06-23 | 1995-07-25 | University Of Washington | Determining cardiac wall thickness and motion by imaging and three-dimensional modeling |
US5722405A (en) * | 1993-04-15 | 1998-03-03 | Adac Laboratories | Method and apparatus for acquisition and processsing of event data in semi list mode |
US5797396A (en) * | 1995-06-07 | 1998-08-25 | University Of Florida Research Foundation | Automated method for digital image quantitation |
US6121775A (en) * | 1998-06-16 | 2000-09-19 | Beth Israel Deaconess Medical Center, Inc. | MRI imaging method and apparatus |
US6261549B1 (en) * | 1997-07-03 | 2001-07-17 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
US6288539B1 (en) * | 1998-09-10 | 2001-09-11 | Pheno Imaging, Inc. | System for measuring an embryo, reproductive organs, and tissue in an animal |
US6387367B1 (en) * | 1998-05-29 | 2002-05-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US20020072670A1 (en) * | 2000-12-07 | 2002-06-13 | Cedric Chenal | Acquisition, analysis and display of ultrasonic diagnostic cardiac images |
US20020072674A1 (en) * | 2000-12-07 | 2002-06-13 | Criton Aline Laure | Strain rate analysis in ultrasonic diagnostic images |
US6438403B1 (en) * | 1999-11-01 | 2002-08-20 | General Electric Company | Method and apparatus for cardiac analysis using four-dimensional connectivity |
US20020151793A1 (en) * | 1998-08-25 | 2002-10-17 | Geiser Edward A. | Autonomous boundary detection system for echocardiographic images |
US20030053667A1 (en) * | 2001-05-17 | 2003-03-20 | Nikolaos Paragios | Variational approach for the segmentation of the left ventricle in MR cardiac images |
US20030069494A1 (en) * | 2001-10-04 | 2003-04-10 | Marie-Pierre Jolly | System and method for segmenting the left ventricle in a cardiac MR image |
US20030161818A1 (en) * | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US20030166272A1 (en) * | 1995-02-02 | 2003-09-04 | Abuljadayel Ilham Saleh | Method of preparing an undifferentiated cell |
US6628743B1 (en) * | 2002-11-26 | 2003-09-30 | Ge Medical Systems Global Technology Company, Llc | Method and apparatus for acquiring and analyzing cardiac data from a patient |
US20030211602A1 (en) * | 2000-04-28 | 2003-11-13 | Anthony Atala | Isolation of mesenchymal stem cells and use thereof |
US20030219898A1 (en) * | 2002-01-14 | 2003-11-27 | Kiminobu Sugaya | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
US6708055B2 (en) * | 1998-08-25 | 2004-03-16 | University Of Florida | Method for automated analysis of apical four-chamber images of the heart |
US20040087850A1 (en) * | 2002-11-01 | 2004-05-06 | Okerlund Darin R. | Method and apparatus for medical intervention procedure planning |
US20040121464A1 (en) * | 2002-09-30 | 2004-06-24 | Rathjen Peter David | Method for the preparation of cells of mesodermal lineage |
US20040132006A1 (en) * | 2002-10-03 | 2004-07-08 | O'donnell Thomas | System and method for using delayed enhancement magnetic resonance imaging and artificial intelligence to identify non-viable myocardial tissue |
US20040137612A1 (en) * | 2001-04-24 | 2004-07-15 | Dolores Baksh | Progenitor cell populations , expansions thereof, and growth of non-hematopoietic cell types and tissues therefrom |
US20040258669A1 (en) * | 2002-11-05 | 2004-12-23 | Dzau Victor J. | Mesenchymal stem cells and methods of use thereof |
US20050033143A1 (en) * | 2003-05-28 | 2005-02-10 | O'donnell Thomas | Automatic optimal view determination for cardiac acquisitions |
US20050054098A1 (en) * | 2003-06-27 | 2005-03-10 | Sanjay Mistry | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20050080328A1 (en) * | 2002-06-04 | 2005-04-14 | General Electric Company | Method and apparatus for medical intervention procedure planning and location and navigation of an intervention tool |
US20050084959A1 (en) * | 2001-10-31 | 2005-04-21 | Hirofumi Hamada | Immortalized mesenchymal cells and utilization thereof |
US20050118712A1 (en) * | 2003-12-02 | 2005-06-02 | Ming-Song Tsai | Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid |
US20050164380A1 (en) * | 2003-11-04 | 2005-07-28 | Trisler G. D. | Stem cell culture medium and method of using said medium and the cells |
US6936281B2 (en) * | 2001-03-21 | 2005-08-30 | University Of South Florida | Human mesenchymal progenitor cell |
US20050197568A1 (en) * | 2002-03-15 | 2005-09-08 | General Electric Company | Method and system for registration of 3d images within an interventional system |
US20050238215A1 (en) * | 2001-10-04 | 2005-10-27 | Marie-Pierre Jolly | System and method for segmenting the left ventricle in a cardiac image |
US6980682B1 (en) * | 2000-11-22 | 2005-12-27 | Ge Medical Systems Group, Llc | Method and apparatus for extracting a left ventricular endocardium from MR cardiac images |
US6994673B2 (en) * | 2003-01-16 | 2006-02-07 | Ge Ultrasound Israel, Ltd | Method and apparatus for quantitative myocardial assessment |
US20060040392A1 (en) * | 2004-04-23 | 2006-02-23 | Collins Daniel P | Multi-lineage progenitor cells |
US20060057657A1 (en) * | 2002-03-12 | 2006-03-16 | Oregon Health & Science University Technology & Research Collaborations | Stem cell selection and differentiation |
US20060073124A1 (en) * | 2004-10-04 | 2006-04-06 | Cellerix, S.L. Universidad Autonoma De Madrid | Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue |
US20060078993A1 (en) * | 2004-08-16 | 2006-04-13 | Cellresearch Corporation Pte Ltd | Isolation, cultivation and uses of stem/progenitor cells |
US20060088890A1 (en) * | 2001-08-15 | 2006-04-27 | Simmons Paul J | Identification and isolation of somatic stem cells and uses thereof |
US20060093586A1 (en) * | 2004-10-20 | 2006-05-04 | Vitro Diagnostics, Inc. | Generation and differentiation of adult stem cell lines |
US7047061B2 (en) * | 2000-12-05 | 2006-05-16 | Koninklijke Philips Electronics N.V. | Method of localizing the myocardium of the heart and method of determining perfusion parameters thereof |
US20060147426A1 (en) * | 2003-01-30 | 2006-07-06 | Schiller Paul C | Multilineage-inducible cells and uses thereof |
US20060177932A1 (en) * | 2002-11-08 | 2006-08-10 | Hiromitsu Nakauchi | Expansion agents for stem cells |
US20060182724A1 (en) * | 2005-02-15 | 2006-08-17 | Riordan Neil H | Method for expansion of stem cells |
US7113623B2 (en) * | 2002-10-08 | 2006-09-26 | The Regents Of The University Of Colorado | Methods and systems for display and analysis of moving arterial tree structures |
US20060223177A1 (en) * | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20070020757A1 (en) * | 2005-05-24 | 2007-01-25 | Whitehead Institute For Biomedical Research | Methods for expansion and analysis of cultured hematopoietic stem cells |
US20070053885A1 (en) * | 2003-05-28 | 2007-03-08 | Shinichi Nishikawa | Mesenchymal stem cell |
US20070054399A1 (en) * | 2003-10-29 | 2007-03-08 | Fcb Pharmicell Co., Ltd. | Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease |
US20070072294A1 (en) * | 2004-09-30 | 2007-03-29 | Doronin Sergey V | Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division |
US20070077652A1 (en) * | 2004-09-16 | 2007-04-05 | Tony Peled | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
US20070077201A1 (en) * | 2004-09-29 | 2007-04-05 | Reading Christopher L | Stem cell expansion and uses |
US20070077649A1 (en) * | 2005-09-06 | 2007-04-05 | Sammak Paul J | Transplantable cell growth niche and related compositions and methods |
US20070092967A1 (en) * | 2003-11-11 | 2007-04-26 | Hoon Han | Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood |
US20070098699A1 (en) * | 2005-02-28 | 2007-05-03 | Donnie Rudd | Process for preparing bone marrow stem cells, and composition related thereto |
US20070105221A1 (en) * | 2003-11-11 | 2007-05-10 | Hoon Han | Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood |
US20070128722A1 (en) * | 2005-12-05 | 2007-06-07 | Industrial Technology Research Institute | Human mesenchymal stem cells and culturing methods thereof |
US20070160583A1 (en) * | 2003-08-06 | 2007-07-12 | Claudia Lange | Method for purifying mesenchymal stem cells |
US20070178591A1 (en) * | 2004-06-25 | 2007-08-02 | Renomedix Institute, Inc | Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
US7252995B2 (en) * | 2002-12-13 | 2007-08-07 | Yu-Show Fu | Method of generating neurons from stem cells and medium for culturing stem cells |
US20070212336A1 (en) * | 2005-10-31 | 2007-09-13 | Fulkerson Loren D | Methods for harvesting and storing autologous stem cells including blood derived hematopoietic stem cells and adipose derived mesenchymal stem cells |
US20070219526A1 (en) * | 2004-03-30 | 2007-09-20 | Toby Freyman | Restenosis Therapy Using Mesenchymal Stem Cells |
US20070218548A1 (en) * | 2004-04-26 | 2007-09-20 | Shin-Ichi Nishikawa | Mesenchymal Stem Cell Processor |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5239591A (en) | 1991-07-03 | 1993-08-24 | U.S. Philips Corp. | Contour extraction in multi-phase, multi-slice cardiac mri studies by propagation of seed contours between images |
US5273040A (en) | 1991-11-14 | 1993-12-28 | Picker International, Inc. | Measurement of vetricle volumes with cardiac MRI |
US5570430A (en) * | 1994-05-31 | 1996-10-29 | University Of Washington | Method for determining the contour of an in vivo organ using multiple image frames of the organ |
US7155042B1 (en) | 1999-04-21 | 2006-12-26 | Auckland Uniservices Limited | Method and system of measuring characteristics of an organ |
US6447453B1 (en) | 2000-12-07 | 2002-09-10 | Koninklijke Philips Electronics N.V. | Analysis of cardiac performance using ultrasonic diagnostic images |
GB0219408D0 (en) * | 2002-08-20 | 2002-09-25 | Mirada Solutions Ltd | Computation o contour |
JP2006524092A (en) | 2003-04-24 | 2006-10-26 | コーニンクレッカ フィリップス エレクトロニクス エヌ ヴィ | Non-invasive left ventricular volume determination |
-
2004
- 2004-04-23 JP JP2006506890A patent/JP2006524092A/en not_active Withdrawn
- 2004-04-23 CN CNB2004800109282A patent/CN100377165C/en active Active
- 2004-04-23 WO PCT/IB2004/050503 patent/WO2004097720A1/en active Application Filing
- 2004-04-23 US US10/554,021 patent/US7603154B2/en active Active
- 2004-04-23 EP EP04729181A patent/EP1620827B1/en active Active
- 2004-04-23 AT AT04729181T patent/ATE470199T1/en not_active IP Right Cessation
- 2004-04-23 DE DE602004027479T patent/DE602004027479D1/en active Active
Patent Citations (74)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5185809A (en) * | 1987-08-14 | 1993-02-09 | The General Hospital Corporation | Morphometric analysis of anatomical tomographic data |
US5107838A (en) * | 1990-02-08 | 1992-04-28 | Kabushiki Kaisha Toshiba | Method of left ventricular volume evaluation using nuclear magnetic resonance imaging |
US5195521A (en) * | 1990-11-09 | 1993-03-23 | Hewlett-Packard Company | Tissue measurements |
US5722405A (en) * | 1993-04-15 | 1998-03-03 | Adac Laboratories | Method and apparatus for acquisition and processsing of event data in semi list mode |
US5435310A (en) * | 1993-06-23 | 1995-07-25 | University Of Washington | Determining cardiac wall thickness and motion by imaging and three-dimensional modeling |
US5433199A (en) * | 1994-02-24 | 1995-07-18 | General Electric Company | Cardiac functional analysis method using gradient image segmentation |
US20030166272A1 (en) * | 1995-02-02 | 2003-09-04 | Abuljadayel Ilham Saleh | Method of preparing an undifferentiated cell |
US5797396A (en) * | 1995-06-07 | 1998-08-25 | University Of Florida Research Foundation | Automated method for digital image quantitation |
US6261549B1 (en) * | 1997-07-03 | 2001-07-17 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells from peripheral blood |
US6387367B1 (en) * | 1998-05-29 | 2002-05-14 | Osiris Therapeutics, Inc. | Human mesenchymal stem cells |
US6121775A (en) * | 1998-06-16 | 2000-09-19 | Beth Israel Deaconess Medical Center, Inc. | MRI imaging method and apparatus |
US20020151793A1 (en) * | 1998-08-25 | 2002-10-17 | Geiser Edward A. | Autonomous boundary detection system for echocardiographic images |
US6708055B2 (en) * | 1998-08-25 | 2004-03-16 | University Of Florida | Method for automated analysis of apical four-chamber images of the heart |
US6288539B1 (en) * | 1998-09-10 | 2001-09-11 | Pheno Imaging, Inc. | System for measuring an embryo, reproductive organs, and tissue in an animal |
US6438403B1 (en) * | 1999-11-01 | 2002-08-20 | General Electric Company | Method and apparatus for cardiac analysis using four-dimensional connectivity |
US20030211602A1 (en) * | 2000-04-28 | 2003-11-13 | Anthony Atala | Isolation of mesenchymal stem cells and use thereof |
US6980682B1 (en) * | 2000-11-22 | 2005-12-27 | Ge Medical Systems Group, Llc | Method and apparatus for extracting a left ventricular endocardium from MR cardiac images |
US7047061B2 (en) * | 2000-12-05 | 2006-05-16 | Koninklijke Philips Electronics N.V. | Method of localizing the myocardium of the heart and method of determining perfusion parameters thereof |
US20020072674A1 (en) * | 2000-12-07 | 2002-06-13 | Criton Aline Laure | Strain rate analysis in ultrasonic diagnostic images |
US20020072670A1 (en) * | 2000-12-07 | 2002-06-13 | Cedric Chenal | Acquisition, analysis and display of ultrasonic diagnostic cardiac images |
US6537221B2 (en) * | 2000-12-07 | 2003-03-25 | Koninklijke Philips Electronics, N.V. | Strain rate analysis in ultrasonic diagnostic images |
US6936281B2 (en) * | 2001-03-21 | 2005-08-30 | University Of South Florida | Human mesenchymal progenitor cell |
US20040137612A1 (en) * | 2001-04-24 | 2004-07-15 | Dolores Baksh | Progenitor cell populations , expansions thereof, and growth of non-hematopoietic cell types and tissues therefrom |
US20030053667A1 (en) * | 2001-05-17 | 2003-03-20 | Nikolaos Paragios | Variational approach for the segmentation of the left ventricle in MR cardiac images |
US7079674B2 (en) * | 2001-05-17 | 2006-07-18 | Siemens Corporate Research, Inc. | Variational approach for the segmentation of the left ventricle in MR cardiac images |
US20060088890A1 (en) * | 2001-08-15 | 2006-04-27 | Simmons Paul J | Identification and isolation of somatic stem cells and uses thereof |
US6961454B2 (en) * | 2001-10-04 | 2005-11-01 | Siemens Corporation Research, Inc. | System and method for segmenting the left ventricle in a cardiac MR image |
US20050238215A1 (en) * | 2001-10-04 | 2005-10-27 | Marie-Pierre Jolly | System and method for segmenting the left ventricle in a cardiac image |
US20030069494A1 (en) * | 2001-10-04 | 2003-04-10 | Marie-Pierre Jolly | System and method for segmenting the left ventricle in a cardiac MR image |
US20050084959A1 (en) * | 2001-10-31 | 2005-04-21 | Hirofumi Hamada | Immortalized mesenchymal cells and utilization thereof |
US20030219898A1 (en) * | 2002-01-14 | 2003-11-27 | Kiminobu Sugaya | Novel mammalian multipotent stem cells and compositions, methods of preparation and methods of administration thereof |
US20030161818A1 (en) * | 2002-02-25 | 2003-08-28 | Kansas State University Research Foundation | Cultures, products and methods using stem cells |
US20060057657A1 (en) * | 2002-03-12 | 2006-03-16 | Oregon Health & Science University Technology & Research Collaborations | Stem cell selection and differentiation |
US20050197568A1 (en) * | 2002-03-15 | 2005-09-08 | General Electric Company | Method and system for registration of 3d images within an interventional system |
US20050080328A1 (en) * | 2002-06-04 | 2005-04-14 | General Electric Company | Method and apparatus for medical intervention procedure planning and location and navigation of an intervention tool |
US20040121464A1 (en) * | 2002-09-30 | 2004-06-24 | Rathjen Peter David | Method for the preparation of cells of mesodermal lineage |
US20040132006A1 (en) * | 2002-10-03 | 2004-07-08 | O'donnell Thomas | System and method for using delayed enhancement magnetic resonance imaging and artificial intelligence to identify non-viable myocardial tissue |
US7113623B2 (en) * | 2002-10-08 | 2006-09-26 | The Regents Of The University Of Colorado | Methods and systems for display and analysis of moving arterial tree structures |
US20040087850A1 (en) * | 2002-11-01 | 2004-05-06 | Okerlund Darin R. | Method and apparatus for medical intervention procedure planning |
US20040258669A1 (en) * | 2002-11-05 | 2004-12-23 | Dzau Victor J. | Mesenchymal stem cells and methods of use thereof |
US20060177932A1 (en) * | 2002-11-08 | 2006-08-10 | Hiromitsu Nakauchi | Expansion agents for stem cells |
US6628743B1 (en) * | 2002-11-26 | 2003-09-30 | Ge Medical Systems Global Technology Company, Llc | Method and apparatus for acquiring and analyzing cardiac data from a patient |
US7252995B2 (en) * | 2002-12-13 | 2007-08-07 | Yu-Show Fu | Method of generating neurons from stem cells and medium for culturing stem cells |
US6994673B2 (en) * | 2003-01-16 | 2006-02-07 | Ge Ultrasound Israel, Ltd | Method and apparatus for quantitative myocardial assessment |
US20060147426A1 (en) * | 2003-01-30 | 2006-07-06 | Schiller Paul C | Multilineage-inducible cells and uses thereof |
US20050033143A1 (en) * | 2003-05-28 | 2005-02-10 | O'donnell Thomas | Automatic optimal view determination for cardiac acquisitions |
US20070053885A1 (en) * | 2003-05-28 | 2007-03-08 | Shinichi Nishikawa | Mesenchymal stem cell |
US20050054098A1 (en) * | 2003-06-27 | 2005-03-10 | Sanjay Mistry | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20050058631A1 (en) * | 2003-06-27 | 2005-03-17 | Kihm Anthony J. | Postpartum cells derived from placental tissue, and methods of making and using the same |
US20070014771A1 (en) * | 2003-06-27 | 2007-01-18 | Ethicon, Incorporated | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20060223177A1 (en) * | 2003-06-27 | 2006-10-05 | Ethicon Inc. | Postpartum cells derived from umbilical cord tissue, and methods of making and using the same |
US20070160583A1 (en) * | 2003-08-06 | 2007-07-12 | Claudia Lange | Method for purifying mesenchymal stem cells |
US20070054399A1 (en) * | 2003-10-29 | 2007-03-08 | Fcb Pharmicell Co., Ltd. | Method for differentiating mesenchymal stem cell into neural cell and pharmaceutical composition containing the neural cell for neurodegenerative disease |
US20050164380A1 (en) * | 2003-11-04 | 2005-07-28 | Trisler G. D. | Stem cell culture medium and method of using said medium and the cells |
US20070092967A1 (en) * | 2003-11-11 | 2007-04-26 | Hoon Han | Method of isolating and culturing mesenchymal stem cell derived from umbilical cord blood |
US20070105221A1 (en) * | 2003-11-11 | 2007-05-10 | Hoon Han | Method of isolating and culturing mesenchymal stem cell derived from cryopreserved umbilical cord blood |
US7101710B2 (en) * | 2003-12-02 | 2006-09-05 | Ming-Song Tsai | Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid |
US20050118712A1 (en) * | 2003-12-02 | 2005-06-02 | Ming-Song Tsai | Two-stage culture protocol for isolating mesenchymal stem cells from amniotic fluid |
US20070219526A1 (en) * | 2004-03-30 | 2007-09-20 | Toby Freyman | Restenosis Therapy Using Mesenchymal Stem Cells |
US20060040392A1 (en) * | 2004-04-23 | 2006-02-23 | Collins Daniel P | Multi-lineage progenitor cells |
US20070218548A1 (en) * | 2004-04-26 | 2007-09-20 | Shin-Ichi Nishikawa | Mesenchymal Stem Cell Processor |
US20070178591A1 (en) * | 2004-06-25 | 2007-08-02 | Renomedix Institute, Inc | Internally administered therapeutic agents for diseases in central and peripheral nervous system comprising mesenchymal cells as an active ingredient |
US20060078993A1 (en) * | 2004-08-16 | 2006-04-13 | Cellresearch Corporation Pte Ltd | Isolation, cultivation and uses of stem/progenitor cells |
US20070077652A1 (en) * | 2004-09-16 | 2007-04-05 | Tony Peled | Methods of ex vivo progenitor and stem cell expansion by co-culture with mesenchymal cells |
US20070077201A1 (en) * | 2004-09-29 | 2007-04-05 | Reading Christopher L | Stem cell expansion and uses |
US20070072294A1 (en) * | 2004-09-30 | 2007-03-29 | Doronin Sergey V | Use of human stem cells and/or factors they produce to promote adult mammalian cardiac repair through cardiomyocyte cell division |
US20060073124A1 (en) * | 2004-10-04 | 2006-04-06 | Cellerix, S.L. Universidad Autonoma De Madrid | Identification and isolation of multipotent cells from non-osteochondral mesenchymal tissue |
US20060093586A1 (en) * | 2004-10-20 | 2006-05-04 | Vitro Diagnostics, Inc. | Generation and differentiation of adult stem cell lines |
US20060182724A1 (en) * | 2005-02-15 | 2006-08-17 | Riordan Neil H | Method for expansion of stem cells |
US20070098699A1 (en) * | 2005-02-28 | 2007-05-03 | Donnie Rudd | Process for preparing bone marrow stem cells, and composition related thereto |
US20070020757A1 (en) * | 2005-05-24 | 2007-01-25 | Whitehead Institute For Biomedical Research | Methods for expansion and analysis of cultured hematopoietic stem cells |
US20070077649A1 (en) * | 2005-09-06 | 2007-04-05 | Sammak Paul J | Transplantable cell growth niche and related compositions and methods |
US20070212336A1 (en) * | 2005-10-31 | 2007-09-13 | Fulkerson Loren D | Methods for harvesting and storing autologous stem cells including blood derived hematopoietic stem cells and adipose derived mesenchymal stem cells |
US20070128722A1 (en) * | 2005-12-05 | 2007-06-07 | Industrial Technology Research Institute | Human mesenchymal stem cells and culturing methods thereof |
Cited By (20)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7864997B2 (en) * | 2006-04-28 | 2011-01-04 | Pie Medical Imaging B.V. | Method, apparatus and computer program product for automatic segmenting of cardiac chambers |
US20070253609A1 (en) * | 2006-04-28 | 2007-11-01 | Aben Jean-Paul M M | Method, Apparatus and Computer Program Product for Automatic Segmenting of Cardiac Chambers |
US20090149734A1 (en) * | 2007-12-07 | 2009-06-11 | Kabushiki Kaisha Toshiba | Diagnostic imaging apparatus, magnetic resonance imaging apparatus, and x-ray ct apparatus |
US8909321B2 (en) * | 2007-12-07 | 2014-12-09 | Kabushiki Kaisha Toshiba | Diagnostic imaging apparatus, magnetic resonance imaging apparatus, and X-ray CT apparatus |
US20100303328A1 (en) * | 2008-01-31 | 2010-12-02 | Koninklijke Philips Electronics N.V. | Automatic 3-d segmentation of the short-axis late-enhancement cardiac mri |
US8509506B2 (en) | 2008-01-31 | 2013-08-13 | Koninklijke Philips N.V. | Automatic 3-D segmentation of the short-axis late-enhancement cardiac MRI |
US8981770B2 (en) * | 2009-07-20 | 2015-03-17 | Koninklijke Philips N.V. | Apparatus and method for influencing and/or detecting magnetic particles |
US20120146632A1 (en) * | 2009-07-20 | 2012-06-14 | Koninklijke Philips Electronics N.V. | Apparatus and method for influencing and/or detecting magnetic particles |
WO2011107528A1 (en) | 2010-03-04 | 2011-09-09 | Europejskie Centrum Zdrowia Otwock Sp. Z O.O. | A device and a method for imaging the left ventricle of a heart |
EP2372639A1 (en) | 2010-03-04 | 2011-10-05 | Europejskie Centrum Zdrowia Otwock Sp. z o.o. | A device and a method for imaging the left ventricle of a heart |
US10495713B2 (en) | 2011-07-07 | 2019-12-03 | The Board Of Trustees Of The Leland Stanford Junior University | Comprehensive cardiovascular analysis with volumetric phase-contrast MRI |
US20150023577A1 (en) * | 2012-03-05 | 2015-01-22 | Hong'en (Hangzhou, China) Medical Technology Inc. | Device and method for determining physiological parameters based on 3d medical images |
US20140005526A1 (en) * | 2012-07-02 | 2014-01-02 | Assaf Govari | Catheter with synthetic aperture mri sensor |
US10398344B2 (en) | 2014-01-17 | 2019-09-03 | Arterys Inc. | Apparatus, methods and articles for four dimensional (4D) flow magnetic resonance imaging |
US11515032B2 (en) | 2014-01-17 | 2022-11-29 | Arterys Inc. | Medical imaging and efficient sharing of medical imaging information |
US10871536B2 (en) | 2015-11-29 | 2020-12-22 | Arterys Inc. | Automated cardiac volume segmentation |
WO2018140596A3 (en) * | 2017-01-27 | 2018-09-07 | Arterys Inc. | Automated segmentation utilizing fully convolutional networks |
US10600184B2 (en) | 2017-01-27 | 2020-03-24 | Arterys Inc. | Automated segmentation utilizing fully convolutional networks |
US10902598B2 (en) | 2017-01-27 | 2021-01-26 | Arterys Inc. | Automated segmentation utilizing fully convolutional networks |
US11551353B2 (en) | 2017-11-22 | 2023-01-10 | Arterys Inc. | Content based image retrieval for lesion analysis |
Also Published As
Publication number | Publication date |
---|---|
WO2004097720A1 (en) | 2004-11-11 |
ATE470199T1 (en) | 2010-06-15 |
EP1620827B1 (en) | 2010-06-02 |
EP1620827A1 (en) | 2006-02-01 |
DE602004027479D1 (en) | 2010-07-15 |
CN1777898A (en) | 2006-05-24 |
CN100377165C (en) | 2008-03-26 |
US7603154B2 (en) | 2009-10-13 |
JP2006524092A (en) | 2006-10-26 |
WO2004097720A8 (en) | 2005-03-31 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US7603154B2 (en) | Non-invasive left ventricular volume determination | |
Nesser et al. | Volumetric analysis of regional left ventricular function with real-time three-dimensional echocardiography: validation by magnetic resonance and clinical utility testing | |
US9924869B2 (en) | Method and apparatus for determining blood flow required, method and apparatus for producing blood flow image, and method and apparatus for processing myocardial perfusion image | |
Goshtasby et al. | Segmentation of cardiac cine MR images for extraction of right and left ventricular chambers | |
Chang et al. | Feasibility of single-beat full-volume capture real-time three-dimensional echocardiography and auto-contouring algorithm for quantification of left ventricular volume: validation with cardiac magnetic resonance imaging | |
US8315447B2 (en) | Method for processing medical image data and magnetic resonance apparatus for recording and processing medical image data | |
Varga-Szemes et al. | Clinical feasibility of a myocardial signal intensity threshold-based semi-automated cardiac magnetic resonance segmentation method | |
US8487933B2 (en) | System and method for multi-segment center point trajectory mapping | |
US20100245360A1 (en) | System and method for center point trajectory mapping | |
Corsi et al. | Quantification of regional left ventricular wall motion from real-time 3-dimensional echocardiography in patients with poor acoustic windows: effects of contrast enhancement tested against cardiac magnetic resonance | |
JP7278056B2 (en) | Improved left ventricular segmentation in contrast-enhanced cine MRI datasets | |
Compas et al. | Radial basis functions for combining shape and speckle tracking in 4D echocardiography | |
Veronesi et al. | Tracking of left ventricular long axis from real-time three-dimensional echocardiography using optical flow techniques | |
FLEAGLE et al. | Automated identification of left ventricular borders from spin-echo magnetic resonance images: experimental and clinical feasibility studies | |
US10776998B1 (en) | Method and system for analysis of 3D deformations and regional function of a heart with 3D SinMod | |
Caiani et al. | Dual triggering improves the accuracy of left ventricular volume measurements by contrast-enhanced real-time 3-dimensional echocardiography | |
US20120008833A1 (en) | System and method for center curve displacement mapping | |
Mazonakis et al. | Development and evaluation of a semiautomatic segmentation method for the estimation of LV parameters on cine MR images | |
Najman et al. | An open, clinically-validated database of 3D+ t cine-MR images of the left ventricle with associated manual and automated segmentations | |
EP3613013B1 (en) | System and method for medical imaging | |
Wesarg et al. | An automated 4D approach for left ventricular assessment in clinical cine MR images | |
Pednekar et al. | Automatic computation of left ventricular ejection fraction from spatiotemporal information in cine‐SSFP cardiac MR images | |
Zhong et al. | Regional assessment of left ventricular surface shape from magnetic resonance imaging | |
Palma et al. | Cardiac Magnetic Resonance protocol and patient preparation | |
Maceira et al. | Global and regional cardiac function |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
AS | Assignment |
Owner name: KONINKLIJKE PHILIPS ELECTRONICS, N.V., NETHERLANDS Free format text: ASSIGNMENT OF ASSIGNORS INTEREST;ASSIGNORS:NOBLE, NICHOLAS MICHAEL IAN;BREEUWER, MARCEL;REEL/FRAME:017886/0851;SIGNING DATES FROM 20050414 TO 20050421 |
|
STCF | Information on status: patent grant |
Free format text: PATENTED CASE |
|
FPAY | Fee payment |
Year of fee payment: 4 |
|
FPAY | Fee payment |
Year of fee payment: 8 |
|
MAFP | Maintenance fee payment |
Free format text: PAYMENT OF MAINTENANCE FEE, 12TH YEAR, LARGE ENTITY (ORIGINAL EVENT CODE: M1553); ENTITY STATUS OF PATENT OWNER: LARGE ENTITY Year of fee payment: 12 |